Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the Covid-19 vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm, Flagship Pioneering, is looking for its next opportunity in this episode of “The David Rubenstein Show: Peer-to-Peer Conversations.” This interview was recorded August 10.
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
   / @davidrubenstein  

Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
https://www.bloomberg.com/peer-to-peer

Learn more about David:
http://www.davidrubenstein.com/
Connect with us on...
Twitter:   / business  
Facebook:   / bloombergbusiness  
Instagram:   / bloombergbusiness